Therapeutics for dementia and Alzheimer's disease: New directions for precision medicine

J A Duce; X Zhu; L H Jacobson; P M Beart

doi:10.1111/bph.14767

Therapeutics for dementia and Alzheimer's disease: New directions for precision medicine

Br J Pharmacol. 2019 Sep;176(18):3409-3412. doi: 10.1111/bph.14767.

Authors

J A Duce^{1

2

3}, X Zhu⁴, L H Jacobson^{2

5}, P M Beart^{2

5}

Affiliations

¹ The ALBORADA Drug Discovery Institute, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK.
² Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, VIC, Australia.
³ School of Biomedical Sciences, Faculty of Biological Sciences, University of Leeds, Leeds, UK.
⁴ Department of Pathology, Case Western Reserve University, Cleveland, Ohio.
⁵ Department of Pharmacology and Therapeutics, School of Biomedical Sciences, University of Melbourne, Parkville, VIC, Australia.

Abstract

This article is part of a themed section on Therapeutics for Dementia and Alzheimer's Disease: New Directions for Precision Medicine. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v176.18/issuetoc.

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Alzheimer Disease / diagnosis
Alzheimer Disease / physiopathology
Alzheimer Disease / therapy*
Dementia / diagnosis
Dementia / physiopathology
Dementia / therapy*
Humans
Precision Medicine / methods*